Over 15 years of experience as a Market Access/AMNOG specialist, including full dossier management
Proven track record in developing pricing and reimbursement strategies as well as conducting cost–benefit assessments
Extensive expertise in submissions to the G-BA and the National Association of Statutory Health Insurance Funds (GKV-SV), including independently leading negotiations
Previously placed as an AMNOG expert through K-Recruiting with excellent client feedback
Select your region & language
Our content and services may vary by location.
)
)
Overview
- Availability
- Asap, full-time, onsite & remote
- Qualification
- Market Access Management (EBS)
- Language Skills
- German (native), English (business fluent)
- Relevant Expertise
- AMNOG process, dossier preparation, market access strategy, pricing, reimbursement, negotiations with G-BA & SHI, RWE, launches, benefit assessment, pharma, biotech
Key-Facts
Extract from previous activities
Biopharmaceutical company, Germany (via K-Recruiting)
AMNOG Expert
Strategic planning and responsibility for all process steps of the early benefit assessment in the context of dossier preparation according to §35a SGB V for reassessments in close cooperation with cross-functional teams, external agencies and external experts
This includes, among other things: Adaptation of the existing Module 2 to the new area of application, Strategy development for successful benefit assessment and price negotiation, Optimization of patient population size including adaptation to the new field of application, Exchange with the dossier teams of the other application areas to ensure a coherent overall strategy
Market access consulting service, Germany
Market Access Consultant
Lead of advisory project and a team of analysts and medical writers
Advice of international biotechnology company regarding EU 3 market access and HTA landscape and qualitative evaluation of the price and reimbursement potential of a new antibody in ophthalmology
Provide overview on General European market access/HTA procedures and requirements, analysis of HTA policies applicable to the new drug, clinical trial design review, endpoint analysis and refinement of study design
Pharmaceutical company, Germany
Market Access Lead
Lead of market access business on national and regional level for acute care portfolio. Full market access budget responsibility, 16 dotted line reports, member of the BU brand team
Lead pricing and reimbursement, prepare for AMNOG process, forge price communication
Define strategy to support hospital reimbursement
Plan and submit applications to G-BA and GKV- Spitzenverband
Evaluate perception of value dossier
Collaborate with leading payer and KOL to win them as trusting and loyal advocates